Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: Shares of the company traded marginally down at $132.47, after having closed up 1.7% on Monday. (bit.ly/2ZkZGze)    J&J said that the FTC had issued a “civil investigative demand,” or CID, the equivalent of a subpoena to determine if the contracting practices were legal. Pfizer Inc filed a lawsuit against J&J in 2017, saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and aimed at blocking sales of Pfizer’s biosimilar called Inflectra. Pfizer said in the lawsuit that J&J had contracted with many insurers to give discounts in exchange for giving preference to Remicade, and to only pay for Inflectra in cases where Remicade proved to be ineffective. Inflectra was approved in 2016 while Remicade went on the market in 1998. Remicade is an infused treatment for chronic autoimmune disorders and costs about $4,000 per dose, or $26,000 a year, Pfizer said in the lawsuit. J&J has denied any wrongdoing and is fighting the Pfizer lawsuit. Pfizer said in a statement that it had received a CID in June. “As Pfizer’s complaint alleges, J&J’s unlawful conduct is designed to prevent Inflectra from being able to compete on its primary point of differentiation – price. Today, Inflectra has an average selling price (ASP) that is more than 22% lower than Remicade,” the company said in a statement. “Despite these facts, J&J has not lost substantial volume or share of sales – counter to what should occur in a competitive market.”  Biosimilars are intended to be lower-cost alternatives to expensive biotech medicines. But since they are made from living cells and it is not possible to make an exact copy of the branded medicine, they are not automatically substituted for the existing branded drug the way a generic drug would be. The drugs treat ailments like rheumatoid arthritis, Crohn’s disease and ulcerative colitis. Claim: J&J says FTC probing efforts to protect arthritis drug Remicade.

A: The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.
****
Q: Paragraph: The city said in a release that it will spend $9.4 million to boost its mobile mental health treatment teams, which were launched in 2016. The city said the new money will be part of a $21 million investment that will lead to the hiring of more social workers, housing specialists and legal assistance employees. The additional workers will be needed to process the 20% increase in mental health referrals the effort is expected to generate, the city said, adding that it will likely reach 900 more people annually. In addition, the city said it plans to spend $11 million to create hospital-based outreach teams to coordinate care for people who frequent emergency rooms and acute care facilities. Mayor Bill de Blasio said the initiative will keep neighborhoods safer. “We have an obligation to address our broken mental health system and do all we can to connect people who are struggling to treatment,” de Blasio said. “That includes the small percentage of those with mental illness that, left untreated, are at risk of committing violence against themselves or others.” The city said its mobile units are in addition to a program that teams up mental health professionals with police officers who engage clients with serious mental health needs and a history of violence. The goal, it said, is to connect those individuals to professional treatment and support systems such as housing or family. Claim: New York City expands mobile program to reach mentally ill.

A: New York City is expanding a program to use mobile units to reach hundreds of people who are mentally ill, the city announced Monday.
****
Q: Paragraph: The 22-year-old man, who has not been named, is among around 250 South Africans who lose their penises each year in botched traditional circumcisions. The nine-hour transplant operation formed part of a pilot study by Tygerberg Hospital in Cape Town and the University of Stellenbosch. The patient was sexually active five weeks later. “To us it means we are ticking most of the boxes where this guy can stand and urinate normally, can have sexual intercourse and his penis function has recovered completely,” Andre van der Merwe, who led the surgical team, told Reuters. “Now to have children is the last thing we wanted.”  He said that independent pregnancy or paternity tests have not been done to verify it was indeed the patient’s child but he had no reason to disbelieve the young man, who was employed and lived in Cape Town. “I know that he can ejaculate normally and there is no reason for him to be infertile. I was expecting a pregnancy at some stage, even though I didn’t expect it this early,” he said. Each year, hundreds of young South African men, mainly from the Xhosa tribe, lose their penises after coming-of-age rituals go wrong. It is hoped Van der Merwe’s pioneering surgery will help them overcome the physical and psychological trauma. Announcing the successful transplant in March, Van der Merwe’s team said the procedure could eventually be offered to men who have lost their penis to cancer or as a last resort for severe erectile dysfunction. Van der Merwe has received requests for penis transplants from as far afield as the United States, Colombia and Russia. “I do believe we will transplant again before the end of the year,” he said. Claim: World's first penis transplant patient to father a child.

A:
A young South African man who had the world’s first successful penis transplant last December has impregnated his girlfriend, the doctor who led the surgery said on Friday.
****